Sellers Dorsey Strengthens Leadership with Jennifer Duke as New Growth Chief

Sellers Dorsey, a prominent healthcare impact strategy firm, has named Jennifer Duke as its Chief Growth Officer, signaling a significant step in enhancing the organization's efforts to expand its influence and effectiveness in the healthcare sector.

With a rich background that spans nearly two decades, Duke is celebrated for her ability to forge innovative paths in business growth and strategic transformation. Her extensive experience covers various areas, including healthcare delivery, population health, managed care, AI-driven digital health, and strategic partnerships between public and private sectors. This wealth of knowledge positions her to align visionary strategies with appropriate outcomes effectively.

Before joining Sellers Dorsey, Duke served at Oracle Health and Life Sciences, where she oversaw global health network advisory services. There, she successfully collaborated with providers, payers, and government entities to implement strategies that harness data to tackle intricate regulatory challenges and improve population health standards. By integrating insights derived from clinical, financial, social, and environmental data, she developed solutions that enhanced service quality, patient experiences, and overall care costs.

Kevin Seabaugh, the Chief Executive Officer of Sellers Dorsey, expressed confidence in Duke's capabilities: "Her leadership and expertise are a perfect fit for Sellers Dorsey. She knows how to translate data insights into scalable solutions quickly—the kind of agility essential for a firm focused on healthcare impact like ours."

In her new role, Duke will spearhead the growth strategy for Sellers Dorsey. This includes managing teams tasked with broadening the firm’s reach across various products, services, and markets. She will closely collaborate with other leaders to ensure that innovative offerings align with client needs, always aiming for measurable and beneficial outcomes for the communities they serve.

Duke shared her enthusiasm for joining the team, stating, "I am eager to contribute to Sellers Dorsey's mission to enhance healthcare quality, access, and outcomes. The firm's profound expertise combined with its commitment to making a difference allows it to be a transformative force in healthcare. I am looking forward to bringing more solutions to a wider array of clients and advancing the health of the populations we serve."

Prior to her position at Oracle, Duke held significant roles focused on business development and strategic growth. She excelled in acquiring and expanding healthcare assets and developing virtual care models designed to improve affordability and access, particularly for underrepresented populations. Her career commenced at Cardinal Health and Johnson & Johnson, where she helped clinical teams embrace groundbreaking medical technologies that support the Quadruple Aim framework—improving patient experience, enhancing population health, reducing costs, and promoting provider well-being.

Duke earned her Bachelor of Science in Business Management from Baker University. Her recent appointment marks a crucial phase for Sellers Dorsey as the firm strives to advance its mission of supporting healthcare systems, Medicaid programs, and the underserved communities they advocate for.

About Sellers Dorsey

Established in 2000, Sellers Dorsey is committed to enhancing healthcare access, quality, and outcomes for the nation's most at-risk populations. They provide strategic consulting, financing, analytic, and tech-enabled services to healthcare stakeholders nationwide. Their expertise lies in developing strategies for the design, implementation, funding, analysis, and sustainability of programs that deliver maximum benefits to underserved communities. With a history of collaborating effectively with Medicaid, their unique impact platform enables clients to navigate the healthcare ecosystem successfully. For more details, visit Sellers Dorsey's website.